Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma.

San Miguel, Jesús F; Schlag, Rudolf; Khuageva, Nuriet K; Dimopoulos, Meletios A; Shpilberg, Ofer; Kropff, Martin; Spicka, Ivan; Petrucci, Maria T; Palumbo, Antonio; Samoilova, Olga S; Dmoszynska, Anna; Abdulkadyrov, Kudrat M; Schots, Rik; Jiang, Bin; Mateos, Maria-Victoria; Anderson, Kenneth C; Esseltine, Dixie L; Liu, Kevin; Cakana, Andrew; van de Velde, Helgi

doi:10.1056/NEJMoa0801479

Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma.

San Miguel, Jesús F

;

Schlag, Rudolf

;

Khuageva, Nuriet K

;

Dimopoulos, Meletios A

;

Richardson, Paul G

;et.al.

(2008) The New England journal of medicine —

Files

SanMiguelJFetalNEJM2008.pdf

Restricted Access
Adobe PDF
355.85 KB

No access

Details

Authors

San Miguel, Jesús F
Author
Schlag, Rudolf
Author
Khuageva, Nuriet K
Author
Dimopoulos, Meletios A
Author
Richardson, Paul G
Author

Abstract

Bortezomib plus melphalan-prednisone was superior to melphalan-prednisone alone in patients with newly diagnosed myeloma who were ineligible for high-dose therapy. (ClinicalTrials.gov number, NCT00111319.)

Affiliations

UCLouvain(MGD) Service d'hématologie

Citations

APA
Chicago
FWB

San Miguel, J. F., Schlag, R., Khuageva, N. K., Dimopoulos, M. A., Shpilberg, O., Kropff, M., Spicka, I., Petrucci, M. T., Palumbo, A., Samoilova, O. S., Dmoszynska, A., Abdulkadyrov, K. M., Schots, R., Jiang, B., Mateos, M.-V., Anderson, K. C., Esseltine, D. L., Liu, K., Cakana, A., et al. (2008). Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma. The New England journal of medicine. https://doi.org/10.1056/NEJMoa0801479